Electroporation Instruments Market 2020-2024 | Demand for Monoclonal Antibodies to Boost Growth | Technavio
Technavio has been monitoring the electroporation instruments market and it is poised to grow by USD 72.67 million during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
The market is fragmented, and the degree of fragmentation will decelerate during the forecast period. BEX Co. Ltd., Bio-Rad Laboratories Inc., Celetrix LLC, Cellectricon AB, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, and Thermo Fisher Scientific Inc. are some of the major market participants. The demand for monoclonal antibodies will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Demand for monoclonal antibodies has been instrumental in driving the growth of the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our electroporation instruments market report covers the following areas:
Electroporation Instruments Market Size
Electroporation Instruments Market Trends
Electroporation Instruments Market Industry Analysis
This study identifies high demand for biopharmaceuticals as one of the prime reasons driving the electroporation instruments market growth during the next few years.
We provide a detailed analysis of vendors operating in the electroporation instruments market, including some of the vendors such as BEX Co. Ltd., Bio-Rad Laboratories Inc., Celetrix LLC, Cellectricon AB, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the electroporation instruments market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist electroporation instruments market growth during the next five years
Estimation of the electroporation instruments market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the electroporation instruments market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of electroporation instruments market vendors
Table Of Contents:
Executive Summary
Market Landscape
Market ecosystem
Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by End-user
Market segments
Comparison by End-user
Pharma and biotech companies - Market size and forecast 2019-2024
Academic and research institutes - Market size and forecast 2019-2024
CROs - Market size and forecast 2019-2024
Market opportunity by End-user
Customer Landscape
Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
APAC - Market size and forecast 2019-2024
South America - Market size and forecast 2019-2024
MEA - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
Vendor landscape
Landscape disruption
Competitive scenario
Vendor Analysis
Vendors covered
Market positioning of vendors
BEX Co. Ltd.
Bio-Rad Laboratories Inc.
Celetrix LLC
Cellectricon AB
Eppendorf AG
Harvard Bioscience Inc.
Lonza Group Ltd.
MaxCyte Inc.
Merck KGaA
Thermo Fisher Scientific Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Ankur Daga, CEO of Angara, a leading online DTC fine jewelry retail brand, has been named the winner of a Gold Stevie® Award in the Best Entrepreneur - Retail category in the 22nd Annual American Business Awards®. Ankur Daga Wins Gold...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...
Results
For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...
Lendistry announces today that it has been selected to administer the Entertainment Business Interruption Fund Program (BIF) to support small Los Angeles County businesses serving the entertainment industry. This program, created and funded through...
Rocky Mountain Liquor Inc. (the "Company" or "Rocky Mountain"), listed on the TSX Venture Exchange (the "Exchange"), today reported its financial results for the full year and fourth quarter ended December 31, 2023.KEY...